Evidence map›Paper›PMID 25653416›Full record

ArticleJournal of clinical microbiology2015

A 10-year retrospective comparison of two target sequences, REP-529 and B1, for Toxoplasma gondii detection by quantitative PCR.

Sorya Belaz, Jean-Pierre Gangneux, Peggy Dupretz, Claude Guiguen, Florence Robert-Gangneux

Abstract readComparative StudyEvaluation Study
In one paragraph

Article in Journal of clinical microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Seroprevalence and molecular detection ofFood and waterborne parasitology · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Comparison of Direct and IndirectMicroorganisms · 2021
    Article
  16. Article
  17. Article
  18. Comparison of the modified agglutination test and real-time PCR for detection ofInternational journal for parasitology. Parasites and wildlife · 2020
    Article
  19. Approach to an Intracranial Mass in Patients With HIV.Current neurology and neuroscience reports · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sorya BelazINSERM U1085, Institut de Recherche en Santé Environnement et Travail, Université Rennes 1, Rennes, France Laboratoire de Parasitologie et Mycologie, Centre Hospitalier Universitaire de Rennes, Rennes, France.
Jean-Pierre GangneuxINSERM U1085, Institut de Recherche en Santé Environnement et Travail, Université Rennes 1, Rennes, France Laboratoire de Parasitologie et Mycologie, Centre Hospitalier Universitaire de Rennes, Rennes, France.
Peggy DupretzLaboratoire de Parasitologie et Mycologie, Centre Hospitalier Universitaire de Rennes, Rennes, France.
Claude GuiguenLaboratoire de Parasitologie et Mycologie, Centre Hospitalier Universitaire de Rennes, Rennes, France.
Florence Robert-GangneuxINSERM U1085, Institut de Recherche en Santé Environnement et Travail, Université Rennes 1, Rennes, France Laboratoire de Parasitologie et Mycologie, Centre Hospitalier Universitaire de Rennes, Rennes, France florence.robert-gangneux@univ-rennes1.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to evaluate the repeated sequence REP-529 compared to that of the B1 gene in the molecular diagnosis of toxoplasmosis by quantitative PCR (qPCR) in routine diagnosis. Over a 10-year period (2003 to 2013), all patients prospectively diagnosed with a positive REP-529 qPCR result for toxoplasmosis were included. All DNA samples (76 samples from 56 patients) were simultaneously tested using the two qPCR methods (REP-529 and B1). The mean cycle threshold (CT) obtained with the B1 qPCR was significantly higher (+4.71 cycles) than that obtained with REP-529 qPCR (P<0.0001). Thirty-one out of 69 extracts (45.6%) positive with REP-529 qPCR were not amplified with the B1 qPCR (relative sensitivity of 54.4% compared to that with REP-529), yielding false-negative results with 15/28 placenta, 5 cord blood, 2 amniotic fluid, 4 cerebrospinal fluid, 1 aqueous humor, 2 lymph node puncture, and 1 abortion product sample. This defect in sensitivity would have left 20/56 patients undiagnosed, distributed as follows: 12/40 congenital toxoplasmosis, 4/5 cerebral toxoplasmosis, 2/8 patients with retinochoroiditis, and 2 patients with chronic lymphadenopathy. This poor performance of B1 qPCR might be related to low parasite loads, since the mean Toxoplasma quantification in extracts with B1 false-negative results was 0.4 parasite/reaction. These results clearly show the superiority of the REP-529 sequence in the diagnosis of toxoplasmosis by PCR and suggest that this target should be adopted as part of the standardization of the PCR assay.

Indexed as

AdultDNA, ProtozoanFemaleHumansInfantInfant, NewbornMaleMolecular Diagnostic TechniquesPregnancyProspective StudiesReal-Time Polymerase Chain ReactionRetrospective StudiesSensitivity and SpecificityToxoplasmaToxoplasmosisDNA, Protozoan

Identifiers

PMID25653416
PMCPMC4365238

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.